Golimumab for uveitis

Ophthalmology

Volumn 118, Issue 9, 2011, Pages 1892.e3-1892.e4

  Cordero Coma, Miguel ^a   Salom, David ^a   Díaz Llopis, Manuel ^a   López Prats, María J ^a   Calleja, Sara ^a  

^a NONE

Author keywords

[No Author keywords available]

Indexed keywords

ADALIMUMAB; CYCLOSPORIN; ETANERCEPT; GOLIMUMAB; INFLIXIMAB; METHOTREXATE; SALAZOSULFAPYRIDINE;

ADULT; ANKYLOSING SPONDYLITIS; CASE REPORT; DRUG SUBSTITUTION; DRUG WITHDRAWAL; HUMAN; JUVENILE RHEUMATOID ARTHRITIS; LETTER; MALE; PRIORITY JOURNAL; PSORIATIC ARTHRITIS; RETINA VASCULITIS; RHEUMATOID ARTHRITIS; UVEITIS;

EID: 80052490380     PISSN: 01616420     EISSN: 15494713     Source Type: Journal    
DOI: 10.1016/j.ophtha.2011.05.019     Document Type: Letter

References (5)

1. E.G. Boyce, J. Halilovic, and O. Stan-Ugbene Golimumab: review of the efficacy and tolerability of a recently approved tumor necrosis factor-α inhibitor Clin Ther 32 2010 1681 1703
2. Z. Ash, and P. Emery Golimumab - a new tool in the armoury against inflammatory arthritis Ann Med 43 2011 133 134
3. P. Emery, R. Fleischmann, D. van der Heijde, E.C. Keystone, M.C. Genovese, and P.G. Conaghan The effects of golimumab on radiographic progression in rheumatoid arthritis: results of randomized controlled studies of golimumab before methotrexate therapy and golimumab after methotrexate therapy Arthritis Rheum 63 2011 1200 1210
4. A. Kavanaugh, I. McInnes, and P. Mease Golimumab, a new human tumor necrosis factor alpha antibody, administered every four weeks as a subcutaneous injection in psoriatic arthritis: Twenty-four-week efficacy and safety results of a randomized, placebo-controlled study Arthritis Rheum 60 2009 976 986
5. R.D. Inman, J.C. Davis Jr, and D. Heijde Efficacy and safety of golimumab in patients with ankylosing spondylitis: results of a randomized, double-blind, placebo-controlled, phase III trial Arthritis Rheum 58 2008 3402 3412